Inventor
COLOMBO JOSEPH MICHAEL
US11 patents
Patents
11 patentsUS9487478B2Nov 8, 2016
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC4 citations82
US9180116B2Nov 10, 2015
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC6 citations82
US9440919B2Sep 13, 2016
Difluorolactam compositions for EP4-mediated osteo related diseases and conditions
CAYMAN CHEMICAL CO INC4 citations81
US9701630B2Jul 11, 2017
Difluorolactam compositions for EP4-mediated osteo related diseases and conditions
CAYMAN CHEMICAL CO INC2 citations70
US11884624B2Jan 30, 2024
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations61
US11345690B2May 31, 2022
Methods of synthesizing a difluorolactam analog
CAYMAN CHEMICAL CO INC0 citations61
US11066361B2Jul 20, 2021
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations61
US9914725B2Mar 13, 2018
Methods of synthesizing a difluorolactam analog
CAYMAN CHEMICAL CO INC0 citations51
US10556862B2Feb 11, 2020
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations49
US10729810B2Aug 4, 2020
Methods, systems, and compositions for promoting bone growth
CAYMAN CHEMICAL CO INC0 citations39
US9688627B2Jun 27, 2017
Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CAYMAN CHEMICAL CO INC0 citations38